Non in Biological Technology
Navigation Links
Non in Biological Technology
January 2009 - Rahu Appoints David Greensmith to Non Executive Directo
NOTTINGHAM, England, February 2 /PRNewswire/ -- - With Photo David has enjoyed a long and highly successful career in the global chemical sector including Managing Director Fujifilm, Chief Operating Officer of Avecia, and as one of the three directors leading Zeneca Specialty Che...-- Target diseases for this collaboration are Diffuse Large Cell Lymphoma, Transformed Follicular Lymphoma, and Chronic Lymphocytic Leukemia -- Collaboration to develop microRNA-based diagnostics test, early detection and prognosis. -- 43,000 people will be diagnosed w...
David Mott Appointed Non Executive Director at Shire
BASINGSTOKE, England, October 31 /PRNewswire-FirstCall/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces today that David Mott will join the Board as a Non Executive Director with immediate effect. Mr Mott is...Microbix Sales Grow 22% For Nine Months
...uted by licensing partners. Capital expenditures will decline as major investments are completed. Pipeline projects are going to be financed through non dilutive agreements with partners. Microbix continues its corporate restructuring to conserve cash and eliminate its burn rate in order to ensure its ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
...Shire upfront payment and $4.7 million of research revenue on reimbursed research and development costs. The differences between U.S. GAAP and non U.S. GAAP financial results are itemized in Tables 2 and 3 and are primarily due to pre-tax stock compensation expense. Use of Non-GAAP Financ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... +27% non GAAP operating income $116 mi... $35 million +$102 million non GAAP diluted earnings per ADS (using actual Q2 ... $0.60 -36% non GAAP diluted earnings per ADS (using full year ...Jatropha Couple Oil Crop Cultivation Technology Commercially Released
...ible oil seeds and research activities thereon & provides support/services from "Soil to Oil" for development and establishment of the non -food Bio-fuel crops. CJP use its proprietary knowledge to implement programmes through its expertise, technology and IPR knowledge creating new i...Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)
...ible oil seeds and research activities thereon & provides support/services from "Soil to Oil" for development and establishment of the non -food Bio-fuel crops. CJP use its proprietary knowledge to implement programmes through its expertise, technology and IPR knowledge creating new i...Phase 3 Cystic Fibrosis Trial Results Presented at European Conference
...ation (PDPE) per subject for the 26 weeks was lower for Bronchitol versus control: overall reduction in rate of 25% (p=0.2). -- There was a non significant increase in time to first PDPE (p=0.1) for the Intention to Treat group, however, for the Per Protocol population, i.e. thos...Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... 822 458 2,659 1,144 Prepaid and other 482 446 21,354 20,310 non current assets 1,584 1,356 Shareholders' equity 20,279 20,522 ......including diphtheria toxoid, is a contraindication to its use. Prevenar does not provide 100% protection against vaccine serotypes or protect against non vaccine serotypes. The decision to administer Prevenar should be based on its efficacy in preventing invasive pneumococcal disease (IPD). About...
...on trial. StemEx is a graft of expanded stem/progenitor cells, derived from a single unit of umbilical cord blood and transplanted in combination with non expanded cells from the same unit. StemEx(R) is being developed by a Joint Venture of Gamida Cell and Teva Pharmaceutical Industries (NASDAQ: TEVA )...
PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
...related to second generation therapeutic proteins. PAREXEL International--Booth #1701 A complimentary white paper, entitled "Best Practices: non Clinical Trial Safety," will be provided at PAREXEL's Booth #1701. A global team of PAREXEL experts will be available for on-site exclusive executive ...Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform
...ible oil seeds and research activities thereon & provides support/services from "Soil to Oil" for development and establishment of the non -food Bio-fuel crops. CJP use its proprietary knowledge to implement programmes through its expertise, technology and IPR knowledge creating new i...500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
...l in Chicago and has been successfully transplanted in the meantime. Alejandra had been diagnosed a few weeks after birth with left ventricular non compaction and dilative cardiomyopathy, a disease that causes the heart muscle to enlarge and weaken. From six months of age, she received medications...Tiens Biotech Group (USA) Reports First Quarter Results
...rty 2,137,742 2,137,742 Deferred income 11,222,672 11,208,844 Total non current liabilities 13,360,414 13,346,586 Total liabilities 47,262,302 47,031,443 EQUITY:...ThromboGenics NV: Business Update
...mboGenics Ltd. Business Highlights Clinical Highlights Microplasmin - Back of the Eye Disease: Phase III clinical program to evaluate non surgical treatment of patients with vitreomacular adhesion. In January 2009, ThromboGenics started the Phase III clinical program of microplasmin for ...Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
... Clinicians and researchers will focus on the state of the art in prevention, recognition, and treatment of cutaneous neoplasms covering melanoma and non melanoma skin cancer as well as lymphomas and rare skin tumors. About Delcath Systems, Inc. Delcath Systems, Inc. is a medical technology co...City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications
...wable biofuel in an evaluation program for boiler applications in the heart of Baltimore. This is the first time the City of Baltimore has evaluated a non fossil fuel in its industrial boilers. In this program, New Generation Biofuels will sell the City biofuel for evaluation in various city munici...Shire begins the year with a strong performance
...(2) +32% non GAAP operating income $327... $226 million +39% non GAAP diluted earnings per ADS ...1 2008 non Non US ...Beckman Coulter Announces First Quarter 2009 Results
...g gains and losses related to operating cash flows, moving these items from non operating expense to cost of sales from non operating expense to cost of sales for both periods. While gross profit de...China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
...Interest paid $167,156 $161,888 Income tax paid $15,927 $8,563 non CASH TRANSACTION: Issuance of shares and receivable from a related party $50,000 $-- ...BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma
... disease, is six to nine months. Treatment of melanoma depends on the stage of the disease with surgical resection being effective in less severe non metastatic forms of the disease. However, survival rates for later Stage III and IV patients are poor, reflecting the lack of any efficacious drugs fo...Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
...0 --- ------- Total current liabilities 6,181,734 8,922,265 non current portion of equipment financing - 1,352,684 Non-current portion of deferred rent ...Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
...410 83,419 Total current liabilities 1,430,117 303,285 Accrued expenses and other liabilities, non current 42,636 53,880 Total liabilities 1,472,753 357,165 Total stockholders' equ...Renowned Stem Cell Researcher Files Study Results With Stemedica
...,600 patients - from treating osteonecrosis in relation to sickle cell disease to the use of bone marrow grafts in the treatment of delayed unions and non unions. Dr. Hernigou has published more than 200 international scientific publications and has participated in more than 100 scientific conferences a...BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
...Sunstone Corporation and Subsidiaries non GAAP Condensed Consolidated Statements of Operatio...tion and Subsidiaries non GAAP Reconciliations ($ amounts... 129 -- 1,014 -- non GAAP Gross Profit $19,329 $ 1,483 $...Helix BioPharma Announces Q2 2009 Financial Results
... 2,164 1,144 Inventory 700 458 Prepaid and other 164 446 25,106 20,310 non current assets 1,218 1,356 Shareholders' 26,324 21,666 equity 24,160 20,522 ......edible oil seeds and research activities thereon & provides support/services from "Soil to Oil" for development and establishment of the non -food Bio-fuel crops. CJP use its proprietary knowledge to implement programmes through its expertise, technology and IPR knowledge creating new ...
Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
... - Year end cash position improved through non core divestitures - - Caliper signs extension of $25 million credit facility through November 2010 - - Non-cash restructuring and goodwill impa......isual feedback and eye fixation method and apparatus. Dr. Dishler has written over 10 peer-reviewed articles for scientific journals as well as other non peer reviewed articles. He has also made over 20 presentations to his peers at major eye meetings and numerous presentations to local and regional me...
Pharmos Corporation Reports 2008 Fourth Quarter Results
...due to the decrease in consulting and professional fees in 2008 result from non recurring 2007 costs related to contractual payment obligations associated ...s in 2007, a one time IRS section 382 tax analysis cost incurred in 2007, a non recurring recruitment fee in 2007 and higher board fees and travel costs in...... December 31, 2008 December 31, 2007 (in thousands of EUR) ASSETS non current assets Property, plant, & 3,429 2,720 equipment Intangible ...
Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
...x-USA, Canada and Barbados) on completion of the transaction. The acquisition is expected to be earnings neutral for 2009 and accretive from 2010 on a non GAAP basis. In addition, small milestone payments may become payable in 2009 and 2010 if certain net sales targets are met. The acquisition is subject...... $3.02bn + 24% $0.77 bn + 6% non GAAP diluted earnings per ADS ...has delivered a strong performance in 2008: - non GAAP diluted earnings per ADS up 36%; - New Pr... 2007 non Non U...
Nanoparticles double their chances of getting into sticky situations
... Chemistry researchers at the University of Warwick have found that tiny nanoparticles could be twice as likely to stick to the interface of two non mixing liquids than previously believed. This opens up a range of new possibilities for the uses of nanoparticles in living cells, polymer composites...Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
... Shire upfront payment and $3.7 million of research revenue on reimbursed research and development costs. The differences between U.S. GAAP and non U.S. GAAP financial results are itemized in Tables 2 through 5 and are primarily due to pre-tax stock compensation expense. Use of Non-GAAP Fina......XIAP) Antisense AEG35156 Given In Combination With Carboplatin/Paclitaxel or the Combination of Carboplatin/Paclitaxel Alone In Patients With Advanced non Small Cell Lung Cancer" is being conducted in the United States in collaboration with U.S. Oncology and additional sites will be opened in Canada. The...
Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
...ndardized, are difficult to reproduce, and have low accuracy. miRview squamous produces a single score which indicates whether a sample is squamous or non squamous NSCLC. - miRview(TM) meso - The test leverages microRNA's high specificity as biomarkers, to differentiate mesothelioma, a cancer conn...CJP Declares the Dates of 3rd Global Jatropha Hi-Tech Agricultural Training Programme
...edible oil seeds and research activities thereon & provides support/services from "Soil to Oil" for development and establishment of the non -food Bio-fuel crops. CJP use its proprietary knowledge to implement programmes through its expertise, technology and IPR knowledge creating new i...Other TagsALKS
BlindedBiovestPalivizumabSynagisKetteringPharmaconSeliciclibMacroglobulinemiaWaldenstromKRXIspinesibTitrationALKSHMPL
Breaking Biology News(10 mins):Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2Improving the odds 2The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2EPA grant to University of Chicago for research on food allergy triggers 9332 1Scientists discover gene mutation responsible for hereditary neuroendocrine tumor 9330 1Scientists discover gene mutation responsible for hereditary neuroendocrine tumor 9330 2Scientists discover gene mutation responsible for hereditary neuroendocrine tumor 9330 3Spring cold snap helps with stream ecosystem research 9328 1Spring cold snap helps with stream ecosystem research 9328 2
Breaking Medicine News(10 mins):Health News:Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges' 2Health News:Reliv International Hires Director of Strategic Development 2Health News:College football linemen take one for the team in terms of health 2Health News:College football linemen take one for the team in terms of health 3Health News:Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts 2Health News:Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts 3Health News:When Parent Is Deployed, Kids Struggle 2Health News:When Parent Is Deployed, Kids Struggle 3
Other Contentspolyacrylamidepolyacrylamidepolyacrylamidepolyacrylamidepolyadenylationpolyadenylationpolyadenylationantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodiespolycistronicpolyclonalpolyclonalpolyclonalpolyclonaldisordersdisordersdisordersdisordersdisordersdisordersdisordersdisordersdisorderspolygenicpolymorphicpolymorphicpolymorphic[0] Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges'[0] Reliv International Hires Director of Strategic Development[0] College football linemen take one for the team in terms of health[0] Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts [0] When Parent Is Deployed, Kids Struggle
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |